PRDX2 and colorectal carcinoma: Removal of PRDX2 also inhibited autophagy flux through the p38 MAPK pathway in HT29 and HCT116 cells, suggesting that PRDX2 could be a multifunction molecule and a promising therapeutic target for CRC treatment.